CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 1,764	$ 3,078
Accounts receivable, net of allowance of $71 in 2024 and $62 in 2023	1,679	1,719
Inventories	2,046	1,918
Prepaid expenses and other current assets	753	706
Current assets of discontinued operations	2,611	2,179
Total current assets	8,853	9,600
Property, plant and equipment, net	2,870	2,871
Goodwill	5,275	5,793
Other intangible assets, net	5,223	5,918
Operating lease right-of-use assets	306	336
Other non-current assets	755	809
Non-current assets of discontinued operations	2,500	2,949
Total assets	25,782	28,276
Current liabilities:
Short-term debt	2,126	0
Current maturities of long-term debt and finance lease obligations	626	2,667
Accounts payable	968	881
Accrued expenses and other current liabilities	1,861	1,915
Current liabilities of discontinued operations	930	1,040
Total current liabilities	6,511	6,503
Long-term debt and finance lease obligations	10,374	11,089
Operating lease liabilities	243	265
Other non-current liabilities	1,076	1,400
Non-current liabilities of discontinued operations	554	551
Total liabilities	18,758	19,808
Commitments and contingencies
Equity:
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2024 and 2023	683	683
Common stock in treasury, at cost, 172,567,636 shares in 2024 and 175,861,893 shares in 2023	(11,059)	(11,230)
Additional contributed capital	6,421	6,389
Retained earnings	14,929	16,114
Accumulated other comprehensive income (loss)	(4,010)	(3,554)
Total Baxter stockholders’ equity	6,964	8,402
Noncontrolling interests	60	66
Total equity	7,024	8,468
Total liabilities and equity	$ 25,782	$ 28,276